共 50 条
- [33] Immunotherapies based on PD-1/PD-L1 pathway inhibitors in ovarian cancer treatment CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2019, 195 (03): : 334 - 344
- [34] Current Advances in PD-1/PD-L1 Blockade in Recurrent Epithelial Ovarian Cancer FRONTIERS IN IMMUNOLOGY, 2022, 13
- [37] Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand- 1 (PD-L1) in ovarian cancer Journal of Ovarian Research, 11